Related resources
Full-text held externally
- PMID: 21718345
- UKPMCID: 21718345
- DOI: 10.1111/j.1365-2230.2011.04108.x
Search for item elsewhere
University researcher(s)
Academic department(s)
What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010.
Foulkes, A C; Grindlay, D J C; Griffiths, C E M; Warren, R B
Clinical and experimental dermatology. 2011;36(6):585-9; quiz 588-9.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
- PMID: 21718345
- UKPMCID: 21718345
- DOI: 10.1111/j.1365-2230.2011.04108.x
Abstract
This review summarizes key clinical findings from 5 guidelines and 21 systematic reviews on psoriasis published or indexed in the period November 2009 to October 2010. The highlights include the British Association of Dermatologists guidelines on the use of biological interventions in psoriasis, and guidelines on the efficacy and use of acitretin. Biological therapies were reviewed for use in specific patient groups (such as those with hepatitis C) and from a health-economics perspective. Another systematic review focused on outcome measures used to assess the severity of psoriasis. Finally, comorbidities including cardiovascular risk were the topic of four systematic reviews.